JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wartenberg, M.
Right arrow Articles by Sauer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wartenberg, M.
Right arrow Articles by Sauer, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 39, 27759-27767, September 24, 1999


Growth Stimulation Versus Induction of Cell Quiescence by Hydrogen Peroxide in Prostate Tumor Spheroids Is Encoded by the Duration of the Ca2+ Response*

Maria Wartenberg, Heike Diedershagen, Jürgen Hescheler, and Heinrich SauerDagger

From the Department of Neurophysiology, University of Cologne, D-50931 Cologne, Germany

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

With increasing size, multicellular prostate tumor spheroids develop regions of quiescent, multidrug-resistant cells expressing the cyclin-dependent kinase inhibitor p27kip1. Treatment of small (diameter 60 ± 20 µm) spheroids with 200 µM hydrogen peroxide (H2O2) resulted in cell cycle arrest owing to up-regulation of p27kip1 and down-regulation of the transcription factor c-Fos. Incubation with 100 nM-1 µM H2O2 led to up-regulation of c-Fos and enhanced tumor growth. Growth stimulation was inhibited by bisindolylmaleimide I, indicating a role for protein kinase C in the signaling cascade that involved the mitogen-activated protein kinase members MEK1,2, ERK1, -2, and c-Jun N-terminal kinase. Changes in Ca2+ influx underlined the differential effects of H2O2. Incubation with 200 µM H2O2 released [Ca2+]i from intracellular stores followed by prolonged Ca2+ influx. Inhibition of influx by Ca2+-free media or Ni2+, La3+, Mn2+ and SKF-96365 prevented the induction of quiescence and stimulated spheroid growth. Consequently, treatment with 200 µM H2O2 in Ca2+-free media down-regulated p27kip1 and increased Fos protein. ATP exerted effects comparably to those observed with H2O2. Encoding growth stimulation by [Ca2+]i release and induction of cell quiescence by prolonged Ca2+ influx may provide a general mechanism for the control of tumor growth.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The role of [Ca2+]i fluctuations in the control of a variety of cell functions including contraction, differentiation, motility, secretion, and proliferation is well established (1). However, there is still uncertainty concerning the mechanisms by which the one second messenger Ca2+ can exert specific effects on discrete intracellular signal pathways that have to be decoded by downstream effectors. Recently, some evidence has emerged that the amplitude and duration of [Ca2+]i signals mediates the differential activation of different transcription factors, indicating that Ca2+ release from intracellular stores and subsequent Ca2+ influx across the plasma membrane activate distinct transcriptional pathways (2).

In the past years an increasing number of publications have demonstrated that reactive oxygen species (ROS)1 including H2O2, Obardot 2, and OH· play an important role as second messengers (3-6) and may promote the constitutive growth of neoplastic tissues (7). Recently, the production of ROS has been found to be related with cytokins such as transforming growth factor-beta -1, interleukin-1, tumor necrosis factor-alpha (8-12) as well as with hormones and peptide growth factors such as angiotensin II, platelet-derived growth factor, and basic fibroblast growth factor (13, 14). The action of ROS in signaling pathways involves [Ca2+]i fluctuations in a variety of preparations (15-18), indicating a fine-tuned interplay between ROS and Ca2+ that may result in a distinct pattern of either gene activation or down-regulation of transcriptional activity.

We have recently shown that 100 nM H2O2 caused release of [Ca2+]i from intracellular thapsigargin-sensitive stores of Du-145 prostate cancer cells grown to the three-dimensional tissue of multicellular tumor spheroids (19). Following H2O2 treatment, a transient up-regulation of c-Fos and a faster kinetics of tumor growth was observed. In the present study treatment of multicellular spheroids with 200 µM H2O2 resulted in tumor growth depression and up-regulation of the cyclin-dependent kinase inhibitor p27kip1. p27kip1 acts as a negative regulator of G1 progression (20) and has been suggested to be associated with intrinsic multidrug resistance in three-dimensional tumor tissues (21). Under these experimental conditions Ca2+ release from intracellular stores was followed by a prolonged period of Ca2+ influx. Since our previous studies demonstrated that the effect of H2O2 on the growth stimulation of tumor spheroids was Ca2+-dependent we tested whether cell cycle activation by 100 nM to 1 µM H2O2 versus cell cycle arrest and induction of cell quiescence by 200 µM H2O2 was owing to the nature of the H2O2-induced Ca2+ response. Our data indicate that the [Ca2+]i release phase of the [Ca2+]i response initiates cell cycle activity. On the other hand prolonged Ca2+ influx is mediating cell cycle arrest, which consequently results in the depression of tumor growth.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Culture Technique of Multicellular Spheroids-- The human prostate cancer cell line DU-145 was kindly provided by Dr. J. Carlsson, Uppsala, Sweden. The cell line was grown routinely in 5% CO2, humidified air at 37 °C with Ham's F-10 medium (Life Technologies, Inc.) supplemented with 10% fetal calf serum (Roche Molecular Biochemicals), 2 mM glutamine, 0.1 mM beta -mercaptoethanol, 2 mM minimal essential medium, 100 IU/ml penicillin, and 100 µg/ml streptomycin (ICN Flow, Meckenheim, Germany). Spheroids were grown from single cells. Cell monolayers were enzymatically dissociated with 0.2% trypsin, 0.05% EDTA (ICN Flow) and seeded in siliconated 250-ml spinner flasks (Integra Biosciences, Fernwald, Germany) with 250 ml of complete medium and agitated at 20 rpm using a Cell-spin stirrer system (Integra Biosciences, Fernwald). Cell culture medium was partially (100 ml) changed every day.

Incubation of Spheroids with H2O2 and ATP-- Small multicellular spheroids (diameter 60 ± 20 µm) were washed in F-10 cell culture medium. They were placed in 8.5-cm diameter plastic nonadhesive culture dishes (Greiner, Solingen, Germany) and incubated for 1 h in E1 medium containing 135 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 10 mM glucose, 10 mM Hepes (pH 7.4 at 37 °C) and supplemented with different concentrations of H2O2 (Sigma) as indicated. In experiments with nominally Ca2+-free solution, CaCl2 was omitted from the incubation medium. The protein kinase C inhibitors bisindolylmaleimide I (1 µM) and H-7 (10 µM) (both from Calbiochem-Novabiochem) were added to the spheroids 1 h before the addition of H2O2. Spheroids were subsequently washed three times in F-10 medium and cultivated in liquid overlay culture. Incubation with ATP (Sigma) was performed in F-10 cell culture medium. ATP was present during an incubation period of 24 h. Spheroid diameters in control and treated samples were monitored every 24 h. Spheroid volumes were calculated according to V = 4/3·pi ·r3. H2O2 did not per se influence the volumes of tumor spheroids. The lifetime of H2O2 in E1 buffer was determined by a luminol-dependent chemiluminescence assay (22). In E1 buffer, no H2O2 degradation within 1 h of incubation was observed (data not shown).

Ca2+ Imaging and Confocal Laser-scanning Microscopy-- [Ca2+]i was monitored using the fluorescent dye fluo-3, AM (Molecular Probes, Eugene, OR). Multicellular spheroids were mounted to poly-L-lysine (Sigma)-coated coverslips and were subsequently loaded for 60 min in F-10 cell culture medium with 10 µM fluo-3, AM, dissolved in dimethyl sulfoxide (final concentration 0.1%) and pluronicTM F-127, which facilitates the solubilization of fluo-3, AM (final concentration <0.025%). After loading, the spheroids were rinsed three times in E1 buffer. Superfusion was performed by gravity at a rate of 10 ml/min. A 90% volume exchange was achieved within 10 s. The experiments were performed at 37 °C. Fluorescence data were recorded using an inverted confocal laser-scanning microscope (LSM 410; Zeiss, Jena, Germany) equipped with a 25× objective, numerical aperture 0.80 (Plan-Neofluar, Zeiss). Fluorescence was excited by the 488-nm line of an argon-ion laser. Emission was recorded using a LP 515-nm filter set. Processing of images (512 × 512 pixels, 8 bit) was carried out by the Time-software facilities of the confocal setup. Full-frame images were acquired and stored automatically at 4-s intervals to a 16-megabyte video memory of the confocal setup. The minimum, maximum, mean, standard deviation, and integrated sum of the pixel values in a region of interest (selected using an overlay mask) were written to a data file and routinely exported for further analysis to the commercially available Sigma Plot (Jandel Scientific, Erkrath, Germany) graphic software. Because fluo-3 does not permit the use of ratio measurements, data are presented in arbitrary units as the percentage of fluorescence variation (F/F0) with respect to the resting level F0, which was set to 100%.

Immunohistochemical Techniques and Quantitative Immunohistochemistry-- The c-Fos (AB-2) polyclonal antibody (5 µg/ml) was obtained from Calbiochem). The monoclonal antibody anti-p27kip1 was obtained from Pharmingen (Hamburg, Germany) and used in a concentration of 2.5 µg/ml. The anti-active MAPK polyclonal antibody directed against ERK1, -2 (dilution 1:20), and the anti-active JNK (dilution 1:20) polyclonal antibody were obtained from Promega (Madison, WI). The polyclonal anti-active p38 MAPK (dilution 1:20) and MEK1, -2 (dilution 1:20) antibodies were obtained from Calbiochem. Antibody staining was performed on whole-mount multicellular spheroids. As secondary antibodies, a Cy3TM-conjugated goat anti-rabbit IgG (H+L) (Jackson ImmunoResearch, West Grove, PA), concentration 1.2 µg/ml, and a Cy5 TM-conjugated F(ab')2 fragment goat anti-mouse IgG (H+L) (Roche Molecular Biochemicals), concentration 3.25 µg/ml, were used. Excitation was performed using a 543-nm and a 633-nm helium-neon laser of the confocal setup. Emission was recorded using LP570 and LP655 nm filter sets, respectively.

For quantitative immunohistochemistry, confocal images of whole mount multicellular spheroids stained with only secondary antibodies (background fluorescence image) and spheroids stained with primary and secondary antibodies were recorded. The pinhole settings of the confocal setup were adjusted to yield optical slices of 20-µm thickness. After subtraction of background fluorescence, the fluorescence signal (counts) was evaluated in 500-µm2 areas of interest by the image analysis software of the confocal setup and was routinely exported for further analysis to the Sigma Plot graphic software.

Immunoblotting-- Multicellular spheroids treated with H2O2 and untreated controls were lysed in 125 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerine, 20 mM dithiothreitol, 1 mM EDTA, 0.01% bromphenol blue. Equal amounts of proteins (15 µg/lane) were electrophoresed on 10 or 15% SDS-polyacrylamide gels. Immunoblots of c-Fos and p27kip1 were prepared by electrophoretic transfer of proteins from SDS-polyacrylamide gels to nitrocellulose by semi-dry Western blotting. The nitrocellulose transfers were incubated for 1 h in blocking buffer (5% lowfat milk powder in phosphate-buffered saline containing 0.1% Tween 20) and then probed for 1 h with 1:300 dilution of polyclonal rabbit anti-c-Fos in blocking buffer or 1:200 dilution of monoclonal anti-p27kip1 in phosphate-buffered saline, 0.1% Tween 20. As secondary antibodies, horseradish peroxidase-conjugated rabbit (dilution 1:2 × 104) or mouse (dilution 1:1 × 104) antibodies were used.

Statistical Analysis-- Data are given as mean values ± S.D., with n denoting the number of experiments that were performed with at least three independent tumor spheroid cultures. Student's t test for unpaired data was applied as appropriate. A value of p < 0.05 was considered significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Expression of p27kip1 during the Growth of Multicellular Tumor Spheroids-- The initial phases (day 1 to day 6) of tumor growth follow an exponential growth kinetics with volume-doubling times of approximately 24 h (19). With the development of quiescent cell areas, which has been previously shown to occur at spheroid diameters of approximately 180 µm (23), growth retardation occurs, and the volume-doubling times increased to 96 ± 30 h (n = 3) (Fig. 1A). By quantitative immunohistochemistry and immunoblotting, a correlation between the growth kinetics of multicellular tumor spheroids and the expression of p27kip1 became obvious (Fig. 1, B and C). Our data indicate that p27kip1 protein levels continuously increased during the first 6 days of spheroids culture. From day 7 on, i.e the time where growth retardation of multicellular tumor spheroids occurred, the increases of p27kip1 protein levels were apparently more pronounced, indicating that with a critical diameter of approximately 180 µm, quiescent cells develop in the tumor tissue of multicellular spheroids.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 1.   Growth kinetics (A) and p27kip1 expression of multicellular tumor spheroids (B and C). Note that multicellular tumor spheroids grow with exponential growth kinetics until they reach spheroid diameters of approximately 180 µm. The decreased growth kinetics of larger spheroids is owed to the increased expression of the cyclin-dependent kinase inhibitor p27kip1 in larger spheroids. The inset in B shows an immunoblot of p27kip1 protein in cell extracts of 3-day and 18-day-old multicellular tumor spheroids. In C, representative 3-day (left) and 18-day-old (right) multicellular spheroids immunostained for p27kip1 are shown. The bar represents 10 µm.

Effects of H2O2 on the Growth Kinetics of Multicellular Tumor Spheroids and the Activation of Mitogen-activated Protein Kinase Pathways-- We have recently reported that nanomolar concentrations of H2O2 induced an enhancement of the growth kinetics of multicellular tumor spheroids (19). To evaluate the differential activation of cell proliferation versus cell quiescence by H2O2, multicellular tumor spheroids with a mean size of 60 ± 20 µm were incubated for 1 h with varying doses of H2O2 ranging from 10 nM to 200 µM, and spheroid size was recorded 24 h thereafter. Fig. 2A shows that 100 nM to 1 µM H2O2 significantly stimulated tumor growth, whereas H2O2 concentrations exceeding 100 µM led to significant growth depression as compared with the control in the absence of H2O2 (n = at least 7 for each experimental condition).


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of different concentrations of H2O2 on the growth of multicellular tumor spheroids and mitogen-activated protein kinase signaling pathways. A, growth stimulation of tumor spheroids was achieved with 100 nM and 1 µM H2O2. Incubation with 100-200 µM H2O2 resulted in growth depression. Spheroids were incubated with H2O2 for 1 h. B, growth stimulation by 1 µM H2O2 is inhibited in the presence of bisindolylmaleimide I (BIM). Spheroid volumes were evaluated 24 h after treatment. The data are presented as relative volume increase (%) in relation to the spheroid volumes before treatment (set to 100%). C, activation of JNK (10 min after the addition of H2O2), MEK1, -2 (10 min after the addition of H2O2), and ERK1, -2 (30 min after the addition of H2O2). Tumor spheroids were probed with phospho-specific antibodies, and immunofluorescence was evaluated by quantitative immunohistochemistry. *p < 0.05, significantly different from control.

Growth stimulation by H2O2 was apparently mediated via activation of protein kinase C, since preincubation with 1 µM bisindolylmaleimide I (n = 3) (Fig. 2B) and 10 µM H7 (not shown) inhibited the observed effects. Furthermore, activation of JNK, MEK1,2, ERK1, -2, but not p38 MAPK (not shown) was observed (Fig. 2C). MEK1, -2 and ERK1, -2 activation occurred after incubation with 1 µM and 200 µM H2O2 and was at its maximum 10 and 30 min, respectively, after the addition of H2O2 to the incubation medium. Activation of the ERK pathway was more pronounced with 200 µM as compared with 1 µm H2O2. JNK activation was observed 10 min after the addition of 1 µM H2O2 to the incubation medium, whereas 200 µM H2O2 did not exert significant effects (n = 3).

To determine possible toxic effects of H2O2, lethal cell stainings were performed with the lethal cell stain ethidium homodimer-1 after 4 days of spheroid culture. No cell lethality was observed with H2O2 concentrations below 0.5 mM. Incubation for 1 h with 0.5 mM and 1 mM H2O2 resulted in a cell lethality of 8 ± 5% and 43 ± 20%, respectively (n = 3) (data not shown). To exclude that 200 µM H2O2 induced apoptosis rather than cell dormancy, spheroids were screened for apoptosis 24 h after H2O2 exposure using terminal deoxynucleotidyltransferase-mediated dUTP-X nick end-labeling (TUNEL). Under the applied experimental conditions, no apoptosis occurred (data not shown).

Dose-dependence of the Duration and Amplitude of H2O2-induced [Ca2+]i Responses-- Cell cycle progression has been shown to be dependent on changes in [Ca2+]i (24-27). To evaluate the involvement of [Ca2+]i signals in the induction of either cell proliferation or cell quiescence by H2O2, single cell [Ca2+]i changes were recorded in tumor spheroids incubated with different concentrations of H2O2 ranging from 100 nM to 500 µM. Nonlethal concentrations of H2O2 elicited a transient rise of [Ca2+]i (Fig. 3, A-C). The duration of the [Ca2+]i response increased with the concentration of H2O2 added to the incubation medium and amounted to 60 ± 16 s, 85 ± 26 s, 246 ± 57 s, 370 ± 70 s, and 590 ± 150 s for 100 nM, 1 µM, 10 µM, 100 µM, and 200 µM H2O2, respectively (Fig. 4A) (n = 4). Incubation of tumor spheroids with 500 µM H2O2, which exerted cytotoxic effects in part of the cells, resulted in a sustained rise of [Ca2+]i (not shown). The amplitude of the [Ca2+]i response was 37 ± 15%, 38 ± 20%, 45 ± 15%, 107 ± 28%, and 139 ± 34% that of the resting [Ca2+]i for 100 nM, 1 µM, 10 µM, 100 µM, and 200 µM H2O2, respectively (Fig. 4B) (n = 4).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Single cell [Ca2+]i responses elicited with different concentrations of H2O2 in multicellular tumor spheroids. A, 100 nM H2O2; B, 10 µM H2O2; C, 200 µM H2O2. H2O2 was present in the incubation medium during the time indicated by the horizontal straight line. Representative tracings are shown.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Duration (A) and amplitude (B) of the single cell [Ca2+]i responses elicited with different concentrations of H2O2 in multicellular tumor spheroids. Note that both the duration and the amplitude are enlarged with increasing concentrations of H2O2.

Activation of Ca2+ Influx Pathways by H2O2-- The data of the present study show that the [Ca2+]i signals elicited by H2O2 are prolonged with rising concentrations of H2O2. To evaluate whether the prolonged [Ca2+]i responses were owing to the activation of Ca2+ influx, spheroids were treated with 200 µM H2O2 under Ca2+-free conditions and in the presence of either Ni2+ (1 mM) and La3+ (50 µM), which have been previously shown to inhibit Ca2+ influx across the plasma membrane (28), or SKF-96365 (10 µM), which is an inhibitor of nonselective Ca2+ entry (29). These conditions led to a significant shortening of the [Ca2+]i response, whereas its amplitude remained unchanged (Fig. 5A and B). The mean duration of the [Ca2+]i response under Ca2+-free conditions and in the presence of Ni2+, La3+, and SKF-96365 was 195 ± 65 s, 190 ± 30 s, 173 ± 35 s, and 194 ± 40 s, respectively (n = 4). A total inhibition of the [Ca2+]i response was obtained by preincubation with 2 µM carbonyl cyanide m-chlorophenylhydrazone, which impairs the respiratory chain and depletes mitochondrial Ca2+ stores (data not shown). Hence, the [Ca2+]i signal elicited with 200 µM H2O2 is owing to mitochondrial Ca2+ release followed by prolonged Ca2+ influx.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of inhibition of Ca2+ influx pathways on the [Ca2+]i responses elicited with 200 µM H2O2. Inhibition of Ca2+ influx was achieved by Ca2+-free solution, La3+, Ni2+, and SKF-96365. Effects on the duration (A) and the amplitude (B) of the [Ca2+]i responses elicited with 200 µM H2O2 are shown. *p < 0.05, significantly different from the sample treated with 200 µM H2O2 under control Ca2+ conditions.

Impact of Inhibition of Ca2+ Influx on the Growth Kinetics of Multicellular Tumor Spheroids-- The working hypothesis of the present study was the assumption that the switch between growth stimulation and induction of cell quiescence by H2O2 is encoded predominantly by the influx component of the [Ca2+]i response, which is, according to the model of capacitative Ca2+ entry proposed by Putney (30), composed of Ca2+ release from intracellular stores followed by Ca2+ influx across the plasma membrane. To validate this assumption, spheroids with a mean diameter of 60 ± 20 µm were treated with 200 µM H2O2 under conditions where Ca2+ influx was inhibited, i.e. under Ca2+-free conditions, in the presence of Mn2+ (50 µM), La3+ (50 µM), and SKF-96365 (10 µM). Spheroid growth was evaluated after 24 h. Our data demonstrate that these conditions led to a significant enhancement of tumor growth as compared with both the untreated control and tumor spheroids treated with 200 µM H2O2 in the presence of 1.8 mM extracellular Ca2+ (n = 4) (Fig. 6). The spheroid volumes amounted to 5.17 × 105 ± 1.9 × 105 µm3, 5.75 × 105 ± 1.75 × 105 µm3, 6.46 × 105 ± 2.24 × 105 µm3, and 6.2 × 105 ± 2.16 × 105 µm3 for Ca2+-free conditions, La3+, Mn2+, and SKF-96365, respectively. This was in the same order of magnitude as achieved after incubation with 1 µM H2O2 (5.56 × 105 ± 2.02 × 105 µm3). The volumes of untreated control spheroids and spheroids treated with 200 µM H2O2 were significantly smaller and amounted to 2.57 × 105 ± 0.85 × 105 µm3 and 1.24 × 105 ± 0.87 × 105 µm3, respectively. Taken together, our data suggest that under conditions where Ca2+ influx was inhibited, 200 µM H2O2 stimulated tumor growth to an extent not significantly different from spheroids treated with growth-stimulating concentrations (100 nM to 1 µM) of H2O2, which indicates that Ca2+ from intracellular stores resulted in cell cycle activation, whereas prolonged Ca2+ influx induced cell quiescence.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of inhibition of Ca2+ influx pathways by Ca2+-free solution, Mn2+, La3+, and SKF-96365 on the growth of multicellular spheroids treated with 200 µM H2O2. Open bars show control conditions. Multicellular spheroids remained either untreated or were treated for 1 h with Ca2+-free solution, La3+ (50 µM) Mn2+ (50 µM), or SKF-96365 (10 µM) in the absence of H2O2. In the experiments indicated by hatched bars either 1 µM or 200 µM H2O2 was present during the time course of the experiment. Spheroid volumes were evaluated 24 h after incubation with H2O2. The mean spheroid volume before treatment amounted to 0.7 × 105 µm3. The data show one of four experiments that yielded comparable results. At least 15 tumor spheroids were evaluated for the respective experimental condition in each experiment. *p < 0.05, significantly different from control.

Inhibition of Ca2+ Influx during Treatment of Multicellular Tumor Spheroids with 200 µM H2O2 Results in Down-regulation of p27kip1 and c-Fos Up-regulation-- The data of the present study demonstrate that treatment of multicellular tumor spheroids with 100 nM to 1 µM H2O2 resulted in cell cycle activation and enhanced tumor growth. Induction of cell quiescence and growth retardation of tumor spheroids was achieved after incubation with 200 µM H2O2. Growth stimulation of multicellular tumor spheroids should therefore be accompanied by a down-regulation of the cyclin kinase inhibitor p27kip1 and up-regulation of the transcription factor c-Fos, which has been demonstrated to be involved in the induction of cell proliferation in multicellular Du-145 prostate tumor spheroids (31). On the other hand, induction of cell quiescence by 200 µM H2O2 should be mediated by p27kip1 up-regulation and down-regulation of Fos protein. Since inhibition of Ca2+ influx, which resulted in an abridgement of the Ca2+ response elicited by 200 µM H2O2, was followed by an enhancement of tumor growth, we expected an up-regulation of Fos protein levels and down-regulation of p27kip1 under these experimental conditions. To evaluate these issues, spheroids with a diameter of 60 ± 20 µm, which express moderate levels of p27kip1 (see Fig. 1), were incubated with either 100 nM or 200 µM H2O2 or 200 µM H2O2 in the absence of extracellular Ca2+. Fos protein levels were evaluated by immunohistochemistry and immunoblotting 1 h after incubation with H2O2, and p27kip1 protein levels were evaluated 24 h thereafter. Fig. 7, A and B, demonstrates by quantitative immunohistochemistry that p27kip1 protein levels were down-regulated and Fos protein levels were up-regulated when spheroids were treated with cell proliferation-inducing nanomolar concentrations (100 nM) of H2O2 (n = 3). However, p27kip1 was up-regulated with tumor growth-depressing micromolar concentrations (200 µM) of H2O2, which consequently down-regulated Fos protein. Under Ca2+-free conditions, i.e. under conditions where Ca2+ influx was abolished, 200 µM H2O2 significantly down-regulated p27kip1 protein levels as compared with the untreated control sample and the sample treated with 200 µM H2O2 in the presence of 1.8 mM extracellular Ca2+. Under these conditions p27kip1 expression was not significantly different from the values achieved after stimulation of cell proliferation with 100 nM H2O2. Consequently, a significant up-regulation of Fos was observed, which is indicative for the induction of cell proliferation and tumor growth. The data obtained with quantitative immunohistochemistry and confocal laser-scanning microscopy could be confirmed by immunoblotting experiments (Fig. 8, A and B) (n = 3). These findings clearly show that [Ca2+]i release from intracellular stores by H2O2 is encoding the induction of cell proliferation, whereas prolonged Ca2+ influx is involved in cell cycle arrest and the induction of cell quiescence.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of H2O2 on Fos (A) and p27kip1 (B) protein levels. Multicellular spheroids were treated either with growth stimulating (100 nM) or with quiescence-inducing (200 µM) concentrations of H2O2. The incubations with 200 µM H2O2 were performed either in the absence or presence of extracellular Ca2+ to evaluate the effect of inhibition of Ca2+ influx pathways on the induction of cell proliferation. The images show representative tumor spheroids. From the upper left to the lower right: control; 100 nM H2O2; 200 µM H2O2; 200 µM H2O2, Ca2+-free. The bars represent 10 µm. The data show one of three experiments, which yielded comparable results. At least 15 tumor spheroids were evaluated for the respective experimental conditions in each experiment. *p < 0.05, significantly different from control.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 8.   c-Fos (A) and p27kip1 (B) immunoblots after treatment of multicellular tumor spheroids with different concentrations of H2O2. Blots were obtained from tumor spheroids treated with 100 nM and 200 µM H2O2. The incubations with 200 µM H2O2 were performed either in the absence or presence of extracellular Ca2+ to evaluate the effect of inhibition of Ca2+ influx pathways on the induction of cell proliferation. Note that incubation with proliferation-stimulating concentrations (100 nM) of H2O2 resulted in up-regulation of c-Fos, whereas incubation with quiescence-inducing concentrations of H2O2 (200 µM) resulted in up-regulation of p27kip1 and down-regulation of c-Fos. Under Ca2+-free conditions, 200 µM H2O down-regulated p27kip1, whereas c-Fos was increased. *p < 0.05, significantly different from control.

ATP-induced [Ca2+]i Signals and Growth Stimulation of Multicellular Prostate Tumor Spheroids by ATP-- It is possible that H2O2 recruits signals in addition to the characteristic [Ca2+]i patterns here described, which may be responsible for the observed effects on proliferation. To investigate this issue, tumor spheroids were incubated with ATP in concentrations ranging from 0.1 to 100 µM. It has been previously shown that in Du-145 prostate cancer cells P2u purinergic receptors are present, which upon activation lead to Ca2+ release from intracellular stores by an inositol trisphosphate-mediated mechanism (32). Our data demonstrate that incubation of tumor spheroids with 0.1 and 1 µM ATP significantly stimulated tumor growth, whereas a concentration of 100 µM ATP resulted in growth depression (n = 3) (Fig. 9A). As described previously (32) ATP induced transient [Ca2+]i responses, which partially exerted oscillatory behavior. The duration of the [Ca2+]i responses increased with rising concentrations of ATP added to the incubation medium and amounted to 36 ± 11 s, 90 ± 80 s, 270 ± 112 s, and 645 ± 260 s for 0.1, 1, 10, and 100 µM ATP, respectively (n = 3) (Fig. 9B). The duration of the [Ca2+]i responses elicited by 1 µM ATP, which exerted the most pronounced stimulatory effect on tumor growth, was not significantly different from the duration of the [Ca2+]i responses achieved with growth-stimulating concentrations of H2O2. This held likewise true for the duration of [Ca2+]i responses elicited with growth-depressing concentrations of ATP, which were not significantly different from the signals achieved with 200 µM H2O2.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 9.   Growth effects and [Ca2+]i responses elicited by ATP in multicellular tumor spheroids. A, effect of different concentrations of ATP on the growth of multicellular tumor spheroids. Spheroid volumes were evaluated after a 24-h incubation with ATP. Data are presented as relative volume increase (%) in relation to the spheroid volume before the addition of ATP to the incubation medium. B, increasing concentrations of ATP prolong the duration of [Ca2+]i responses. Note that prolongation of the ATP-induced [Ca2+]i responses with increasing concentrations of ATP results in growth retardation of tumor spheroids.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The major obstacle for the efficacy of cancer therapy is the development of features of resistance toward anticancer agents, which has been attributed to the development of a low proliferative cell fraction in the depth of the tumor tissue (33-35). Recently, we have shown that prostate cancer cells grown in multicellular tumor spheroid culture develop with increasing size an intrinsic P-glycoprotein-mediated drug resistance that could be attributed to quiescent cell areas (36). In corroboration with our previous results, it has been demonstrated that compact multicellular spheroids that express high levels of cell quiescence-related p27kip1 are less susceptible toward anticancer agents, and p27 has therefore been suggested to be a survival gene (21). Since anticancer agents like vinca alkaloids and antimetabolites are most active during a particular phase of the cell cycle, recruitment of cells into the cell cycle may chemosensitize for chemotherapy. Indeed it has been shown that tumors with a high S-phase fraction respond better toward chemotherapy than tumors with a low proliferating, quiescent cell fraction (33-35). This implicates that a better knowledge of the molecular mechanisms regulating cancer cell proliferation could potentially be exploited to overcome problems encountered with conventional cell cycle recruitment strategies.

The data of the present study demonstrate that the cyclin-dependent kinase inhibitor p27kip1 is up-regulated in multicellular prostate spheroids with increasing spheroid growth, indicating the emergence of a low proliferating, quiescent cell population in the tissue. Our data furthermore indicate that intracellular redox modulation by 100 nM to 1 µM H2O2 led to cell cycle activation, up-regulation of the proliferation-associated transcription factor c-Fos, down-regulation of p27kip1, and enhanced tumor growth. Incubation of multicellular tumor spheroids with nonlethal 200 µM concentrations of H2O2 resulted in down-regulation of c-Fos, up-regulation of p27kip1, and consequently in tumor growth retardation. Growth stimulation of cells by nanomolar concentrations of H2O2 has previously been observed in a number of different cell types, e.g. cultured human and rat fibroblasts (37, 38), epidermal cells (39), and smooth muscle cells (40, 41). Higher concentrations of H2O2 in a range of 50-100 µM have been shown to induce cell cycle arrest in the G0/G1 phase of the cell cycle, whereas 300-400 µM H2O2 have been demonstrated to result in apoptosis (42).

Although the differential effects of different concentrations of H2O2 on cell cycle activation and the induction of cell quiescence and apoptosis are now emerging, the signal transduction mechanisms underlying these phenomena are not well defined. [Ca2+]i changes after treatment of cells with H2O2 have been observed in a variety of preparations (15, 16, 43). However, the interrelation between H2O2-induced signal transduction pathways and [Ca2+]i changes lacks conclusive investigations. Several redox-mediated signal transduction pathways seem to depend on [Ca2+]i changes. It has been shown in a recent study that big mitogen-activated protein kinase 1 (BMK1) or ERK5 activation in rat vascular smooth muscle cells by H2O2 is Ca2+-dependent (45). In Jurkat cells c-Jun expression following treatment H2O2 was inhibited after chelation of [Ca2+]i by BAPTA (18). The activation of the redox-regulated transcription factor NF-kappa B seems to depend critically on [Ca2+]i (47). Furthermore, in chicken B cells, Ca2+ dependence of the nonreceptor tyrosine kinase Syk was demonstrated. Syk acts upstream of JNK, which is activated upon oxidative stress in this cell line (48). In a recent study of our group, we have demonstrated that cell cycle activation following treatment of multicellular tumor spheroids by nanomolar concentrations of H2O2 is a Ca2+-dependent process (19). The data of our previous study demonstrated that the [Ca2+]i transient induced by nanomolar concentrations of H2O2 was predominantly mediated by Ca2+ from intracellular stores, since a comparable transient was observed in Ca2+-free solution. The present study demonstrates that cell cycle activation by H2O2 was mediated via an activation of protein kinase C, since the protein kinase C inhibitor bisindolylmaleimide I inhibited the observed growth stimulation. Our data furthermore suggest that the downstream signal transduction cascade is operating via activation of MEK1, -2, ERK1, -2, and JNK but not p38. Interestingly, MEK1, -2 and ERK1, -2 activation was observed with both low (1 µM) and high (200 µM) concentrations of H2O2. However, JNK activation was only observed with cell cycle-activating concentrations of H2O2 (1 µM), whereas after incubation with 200 µM H2O2, which retarded tumor growth and increased p27kip1, JNK was not significantly activated. This may indicate that a dynamic balance between ERK and JNK pathway is important in determining whether cell cycle activity is stimulated or cell quiescence is induced in multicellular tumor spheroids. An activation of the ERK-signaling cascade by oxidative stress has been demonstrated for several preparations (49-52). Likewise, evidence for JNK activation by ROS has been recently provided (9, 54). As is the case for ERK, JNK activation has been shown to be involved in signal transduction pathways leading to the activation of cell proliferation in various cell types (55-60).

In the present study we showed that both the duration and the amplitude of the [Ca2+]i response enlarged with increasing doses of H2O2. Nonlethal concentrations (100 nM to 200 µM) of H2O2 induced transient [Ca2+]i responses, whereas lethal (500 µM to 1 mM) concentrations of H2O2 elicited sustained [Ca2+]i responses. Because it has been recently reported that JNK in B cells is selectively activated by short transient [Ca2+]i responses (46), it sounds reasonable that in the present study higher concentrations of H2O2, which elicited prolonged [Ca2+]i signals, failed to induce a significant activation of JNK. The increase in duration of the [Ca2+]i transient observed with rising concentrations of H2O2 was predominantly owing to Ca2+ influx, since under Ca2+-free conditions, after the addition of divalent and trivalent cations and in the presence of SKF-96365, which has been demonstrated to inhibit nonselective cation channels (29), the duration of the [Ca2+]i response was significantly shortened. Because high K+ solution did not raise [Ca2+]i and the phenylalkylamine verapamil did not impair the H2O2-induced [Ca2+]i response, a participation of voltage-dependent Ca2+ channels in the observed Ca2+ influx was excluded.2 To evaluate whether the duration of the Ca2+ signal, i.e. the Ca2+ influx phase, encoded the information for induction of cell proliferation versus induction of cell quiescence, multicellular tumor spheroids were incubated with quiescence-inducing micromolar (200 µM) concentrations of H2O2 under conditions where Ca2+ influx was inhibited, i.e. Ca2+-free solution, presence of divalent and trivalent cations, presence of SKF- 96365. Subsequently c-Fos, p27kip1 and tumor spheroid growth was monitored. Our data clearly show that abridgement of the [Ca2+]i transient elicited with 200 µM H2O2 by inhibition of Ca2+ influx resulted in up-regulation of Fos protein levels and enhanced tumor growth, whereas p27kip1 was down-regulated, and slow-cycling cells were obviously recruited for the cell cycle. Under these experimental conditions the amplitude of the [Ca2+]i response was not significantly different from the amplitude observed with 200 µM H2O2 in the presence of control extracellular Ca2+. Hence, we concluded that the duration of the [Ca2+]i response, which is mainly characterized by prolonged Ca2+ influx, is the determinant for the switch between H2O2-induced cell cycle activation and induction of cell quiescence. This implies that H2O2 does not act per se on transcription factors and cyclins involved in the regulation of the cell cycle but is critically dependent, at least as a cofactor, on changes in [Ca2+]i.

The data of the present study demonstrate that H2O2-induced [Ca2+]i signals promote activation of the cell cycle when they are short-termed, transient, and mediated predominantly by Ca2+ release from intracellular stores. They induce cell cycle arrest when long-lasting, but transient Ca2+ influx is activated. In the present study low concentrations of ATP stimulated tumor growth, whereas higher concentrations led to tumor growth retardation. Since increasing concentrations of ATP resulted in prolonged [Ca2+]i responses, the duration of the [Ca2+]i may provide a general means by which Du-145 prostate cancer cells differentially regulate cell proliferation versus cell quiescence. Furthermore this observation may indicate that H2O2 may recruit additional signal transduction pathways, i.e. by the activation of hormone or growth factor receptors or their downstream targets. The activation of fibroblast growth factor receptor type I (44) and epidermal growth factor (53) by H2O2, which has been recently reported, points to this direction. Further investigations on the interrelation between ROS and [Ca2+]i signals are essential since constitutive ROS production appears to be characteristic for tumor cells (7) and may be one of the prerequisites for the loss of cell cycle control that occurs during neoplastic tissue growth.

    ACKNOWLEDGEMENTS

Immunoblots and quantitative immunohistochemistry of c-Fos are parts of the Ph.D. thesis of H. Diedershagen.

    FOOTNOTES

* This work has been supported by the Graduiertenkolleg Molecular Basis of Pathophysiological Processes and by the Cologne Fortune Program, University of Cologne (project 98).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Neurophysiology, Robert-Koch-Str. 39, D-50931 Cologne, Germany. Tel.: 49-221-4786976; Fax: 49-221-4786965; E-mail: hs@physiologie.uni-koeln.de.

2 H. Sauer, M. Wartenberg, and J. Hescheler, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: ROS, reactive oxygen species; ERK, extracellular signal-regulated kinase; MEK1, -2, mitogen-activated protein kinase kinase 1 and 2, respectively; JNK, c-Jun N-terminal kinase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Berridge, M. J. (1995) Bioessays 17, 491-500[CrossRef][Medline] [Order article via Infotrieve]
2. Dolmetsch, R. E., Lewis, R. E., Goodnow, C. C., and Healy, J. I. (1997) Nature 386, 855-858[CrossRef][Medline] [Order article via Infotrieve]
3. Irani, K., Xia, Y., Zweier, J. L., Sollot, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P. J. (1997) Science 275, 1649-1652[Abstract/Free Full Text]
4. Wung, B. S., Cheng, J. J., Hsieh, H. J., Shyy, Y. J., and Wang, D. L (1997) Circ. Res. 81, 1-7[Abstract/Free Full Text]
5. Lander, H. M., Ogiste, J. S., Teng, K. K., and Novogrodsky, A. (1995) J. Biol. Chem. 270, 21195-21198[Abstract/Free Full Text]
6. Goldstone, S. D., Milligan, A. D., and Hunt, N. H. (1996) Biochim. Biophys. Acta 1314, 175-182[Medline] [Order article via Infotrieve]
7. Szatrowski, T. P., and Nathan, C. F. (1991) Cancer Res. 51, 794-798[Abstract/Free Full Text]
8. Thannickal, V. J., Aldweib, K. D., and Fanburg, B. L. (1998) J. Biol. Chem. 273, 23611-23615[Abstract/Free Full Text]
9. Lo, Y. Y. C., Wong, J. M. S., and Cruz, T. F. (1996) J. Biol. Chem. 271, 15703-15707[Abstract/Free Full Text]
10. Morita, Y., Clemens, M. G., Miller, L. S., Rangan, U., Kondo, S., Miyasaka, M., Yoshikawa, T., and Bulkley, G. B. (1995) Am. J. Physiol. 269, H1833-H1842[Abstract/Free Full Text]
11. Krieger-Brauer, H. I., and Kather, H. (1995) Biochem. J. 307, 549-556
12. Lo, Y. Y., Conquer, J. A., Grinstein, S., and Cruz, T. F. (1998) J. Cell. Biochem. 69, 19-29[CrossRef][Medline] [Order article via Infotrieve]
13. Puri, P. L., Avataggiati, M. L., Burgio, V. L., Chirillo, P., Collepardo, D., Natoli, G., Balsano, C., and Levrero, M. (1995) Ann. N. Y. Acad. Sci. 752, 394-405[Medline] [Order article via Infotrieve]
14. Sundaresan, M., Yu, Z. X., Ferrans, V. J., Sulciner, D. J., Gutkind, J. S., Irani, K., Goldschmidt-Clermont, P. J., and Finkel, T. (1996) Biochem. J. 318, 379-382
15. Volk, T., Hensel, M., and Kox, W. J. (1997) Mol. Cell Biochem. 171, 11-21[CrossRef][Medline] [Order article via Infotrieve]
16. Bauer, V., Oike, M., Tanaka, H., Inoue, R., and Ito, Y. (1997) Br. J. Pharmacol. 121, 867-874[CrossRef][Medline] [Order article via Infotrieve]
17. Meyer, T. N., Gloy, J., Hug, M. J., Greger, R., Schollmeyer, P., and Pavenstädt, H. (1996) Kidney Int. 49, 388-395[Medline] [Order article via Infotrieve]
18. Liu, B., Hackshaw, K. V., and Whistler, R. L. (1996) J. Interferon Cytokine Res. 16, 77-90[Medline] [Order article via Infotrieve]
19. Sauer, H., Diedershagen, H., Hescheler, J., and Wartenberg, M. (1997) FEBS Lett. 419, 201-205[CrossRef][Medline] [Order article via Infotrieve]
20. Kwon, T. K., Buchholz, M. A., Chrest, F. J., and Nordin, A. A. (1996) Cell Growth Differ. 7, 1305-1313[Abstract]
21. St. Croix, B., Fl℘renes, V. A., Rak, J. W., Flanagan, M., Bhattacharya, N., Slingerland, J. M., Kerbel, R. S. (1996) Nat. Med. 2, 1204-1210[CrossRef][Medline] [Order article via Infotrieve]
22. Wymann, M. P., von Tscharner, V., Deranleau, D. A., and Baggiolini, M. (1987) Anal. Biochem. 165, 371-378[CrossRef][Medline] [Order article via Infotrieve]
23. Sauer, H., Ritgen, J., Hescheler, J., and Wartenberg, M. (1998) J. Cell. Physiol. 175, 129-140[CrossRef][Medline] [Order article via Infotrieve]
24. Husain, M., Bein, K., Alper, S. L., Simons, M., and Rosenberg, R. D. (1997) Circ. Res. 80, 617-626[Abstract/Free Full Text]
25. Swanson, C. A., Arkin, A. P., and Ross, J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1194-1199[Abstract/Free Full Text]
26. Heist, E. K., and Schulman, H. (1998) Cell Calcium 23, 103-114[CrossRef][Medline] [Order article via Infotrieve]
27. Santella, L. (1998) Biochim. Biophys. Res. Commun. 244, 317-324[CrossRef][Medline] [Order article via Infotrieve]
28. Shibuya, I., and Douglas, W. W. (1992) Endocrinology 131, 1936-1941[Abstract]
29. Cabello, O. A., and Schilling, W. P. (1993) Biochem. J. 295, 357-366
30. Putney, J. W., Jr. (1990) Cell Calcium 11, 611-624[CrossRef][Medline] [Order article via Infotrieve]
31. Sauer, H., Hescheler, J., Reis, D., Diedershagen, H., Niedermeier, W., and Wartenberg, M. (1997) Br. J. Cancer 75, 1481-1488[Medline] [Order article via Infotrieve]
32. Wasilenko, W. J., Cooper, J., Palad, A. J., Somers, K. D., Blackmore, P. F., Rhim, J. S., Whright, G. L., Jr., and Schellhammer, P. F. (1997) Prostate 30, 167-173[CrossRef][Medline] [Order article via Infotrieve]
33. Hietanen, P., Blomqvist, C., Wasenius, V. M., Niskanen, E., Franssila, K., and Nordling, S. (1995) Br. J. Cancer 71, 1029-1032[Medline] [Order article via Infotrieve]
34. Remvikos, Y., Mosseri, V., Zajdela, A., Fourquet, A., Durand, J. C., Pouillard, P., and Magdelenat, H. (1993) Ann. N. Y. Acad. Sci. 698, 193-203[Medline] [Order article via Infotrieve]
35. Olive, P. L., and Durand, R. E. (1994) Cancer Metastasis Rev. 13, 121-138[CrossRef][Medline] [Order article via Infotrieve]
36. Wartenberg, M., Frey, C., Diedershagen, H., Ritgen, J., Hescheler, J., and Sauer, H. (1998) Int. J. Cancer 75, 855-863[CrossRef][Medline] [Order article via Infotrieve]
37. Burdon, R. H., Gill, V., and Rice-Evans, C. (1990) Free Radical Res. Commun. 11, 65-76[Medline] [Order article via Infotrieve]
38. Murrell, G. A., Francis, M. J. O., and Bromley, L. (1990) Biochem. J. 265, 659-665[Medline] [Order article via Infotrieve]
39. Muehlematter, D., Larsson, R., and Cerutti, P. (1988) Carcinogenesis 9, 239-245[Abstract/Free Full Text]
40. Rao, G. N., Glasgow, W. C., Eling, T. E., and Runge, M. S. (1996) J. Biol. Chem. 271, 27760-27764[Abstract/Free Full Text]
41. Hebert, J. M., Bono, F., and Savi, P. (1996) FEBS Lett. 395, 43-47[CrossRef][Medline] [Order article via Infotrieve]
42. Bladier, C., Wolvetang, E. J., Hutchinson, P., de Haan, J. B., and Kola, I. (1997) Cell Growth Differ. 8, 589-598[Abstract]
43. Bielefeldt, K., Whiteis, C. A., Sharma, R. V., Abboud, F. M., and Conklin, J. L. (1997) Am. J. Physiol. 272, G1439-G1450[Abstract/Free Full Text]
44. Rao, G. N. (1997) Cell. Signal. 9, 181-187[CrossRef][Medline] [Order article via Infotrieve]
45. Abe, J., Kusuhara, M., Ulevitch, R. J., Berk, B. C., and Lee, J. D. (1996) J. Biol. Chem. 271, 16586-16590[Abstract/Free Full Text]
46. Dolmetsch, R. E., Lewis, R. S., Goodnow, C. C., and Healy, J. I. (1997) Nature 388, 308[CrossRef]
47. Pahl, H. C., and Baeuerle, P. A. (1996) FEBS Lett. 392, 129-136[CrossRef][Medline] [Order article via Infotrieve]
48. Qin, S., Minami, Y., Hibi, M., Kurosaki, T., and Yamamura, H. (1997) J. Biol. Chem. 272, 2098-2103[Abstract/Free Full Text]
49. Tournier, C., Thomas, G., Pierre, J., Jacquemin, C., Pierre, M., and Saunier, B. (1997) Eur. J. Biochem. 244, 587-595[Medline] [Order article via Infotrieve]
50. Griffith, C. E., Zhang, W., and Wange, R. L. (1998) J. Biol. Chem. 273, 10771-10776[Abstract/Free Full Text]
51. Abe, M. K., Kartha, S., Karpova, Y. Y., Li, J., Liu, P. T., Kuo, W. L., and Hershenson, M. B. (1998) Am. J. Respir. Cell Mol. Biol. 18, 562-569[Abstract/Free Full Text]
52. Kanterewicz, B. I., Knapp, L. T., and Klann, E. (1998) J. Neurochem. 70, 1009-1016[Medline] [Order article via Infotrieve]
53. Goldkorn, T., Balaban, N., Matsukuma, K., Chea, V., Gould, R., Last, J., Chan, C., and Chavez, C. (1998) Am. J. Respir. Cell Mol. Biol. 19, 786-798[Abstract/Free Full Text]
54. Wang, X., Martindale, J. L., Liu, Y., and Hobrook, N. J. (1998) Biochem. J. 333, 291-300
55. Kilger, E., Kieser, A., Baumann, M., and Hammerschmidt, W. (1998) EMBO J. 17, 1700-1709[CrossRef][Medline] [Order article via Infotrieve]
56. Brandstetter, T., Ninci, E., Falken, U., Wagner, E., Hess, R., and Bauknecht, T. (1998) Int. J. Cancer 75, 847-854[CrossRef][Medline] [Order article via Infotrieve]
57. Goke, M., Kanai, M., Lynch-Devaney, K., and Podolsky, D. K. (1998) Gastroenterology 114, 697-705[CrossRef][Medline] [Order article via Infotrieve]
58. Alblas, J., Slager-Davidov, R., Steenbergh, P. H., Sussenbach, J. S., and van der Burg, B. (1998) Oncogene 26, 131-139
59. Smith, A., Ramos-Morales, F., Ashworth, A., and Collins, M. (1997) Curr. Biol. 7, 893-896